Clinical Trials on Malignant Meningeal Neoplasms in Australia

Total 4861 results

Fermiscan Ltd

Unknown

Use of Hair to Diagnose Breast Cancer

Breast Neoplasms

Australia
University of Sydney

Completed

Australian Screening Mammography Decision Aid Trial (ASMDAT)

Breast Neoplasms

Australia
Hoffmann-La Roche

Completed

A Study of Vemurafenib in Metastatic Melanoma Participants With Brain Metastases

Malignant Melanoma

Spain, United States, Canada, Germany, Netherlands, France, Italy, United Kingdom, Israel, Australia
Ludwig Institute for Cancer Research
Austin Health; Peter MacCallum Cancer Institute

Completed

Study of NY-ESO-1 ISCOMATRIX® in Patients With Measurable Stage III or IV Melanoma

Melanoma

Australia
Galderma R&D

Completed

PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Patients With Primary Nodular Basal Call Carcinoma

Basal Cell Carcinoma

Australia
Centre hospitalier de l'Université de Montréal...
Austin Health

Recruiting

Adaptive RadioTherapy for OroPharynx Cancer (ART-OPC)

MRI | Dysphagia | Oropharynx Cancer | Radiotherapy Side Effect | Radiotherapy; Complications

Canada, Australia
Anwita Biosciences

Recruiting

Phase 1 Study of AWT020 in Advanced Cancer

Advanced Cancer

Australia
St Vincent's Hospital, Sydney
Clarity Pharmaceuticals Ltd

Completed

Copper-64 SAR Bombesin in PSMA Negative Prostate Cancer (BOP) (BOP)

Prostate Cancer

Australia
Queensland Centre for Gynaecological Cancer
Royal Brisbane and Women's Hospital; The University of Queensland

Completed

Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer (IMAGE)

Ovarian Cancer Stage IV | Ovarian Cancer Stage III

Australia
Australasian Gastro-Intestinal Trials Group

Completed

Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study (CONTROL NETS)

Midgut Neuroendocrine Tumours | Pancreatic Neuroendocrine Tumours

Australia
Western Sydney Local Health District

Recruiting

Cold Snare Polypectomy for Duodenal Adenomas in Familial Adenomatous Polyposis (COPDA)

Familial Adenomatous Polyposis

Australia
Peter MacCallum Cancer Centre, Australia
Celgene Corporation

Unknown

A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression

Multiple Myeloma

Australia
GlaxoSmithKline

Withdrawn

A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma

Cancer

Australia
Peter MacCallum Cancer Centre, Australia
Celgene Corporation; Janssen-Cilag Ltd.

Unknown

A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma

Multiple Myeloma

Australia
Bayside Health
Gilead Sciences

Unknown

Intermittent Liposomal Amphotericin B Primary Prophylaxis

Acute Myeloid Leukemia

Australia
St George Hospital, Australia

Completed

Mouth Care Regimes During Radiotherapy

Head and Neck Neoplasms

Australia
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

Locally Advanced Unresectable or Metastatic Solid Tumors

Australia
Trans Tasman Radiation Oncology Group

Active, not recruiting

STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing) (STARS)

Breast Cancer

Australia, New Zealand
Melanoma Institute Australia
Merck Sharp & Dohme LLC

Not yet recruiting

Neoadjuvant Pembrolizumab and Lenvatinib for Mucosal Melanoma (Neo PeLeMM)

Mucosal Melanoma

Australia
Peter MacCallum Cancer Centre, Australia

Completed

Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours (RAPPORT)

Renal Cell Carcinoma

Australia
Peter MacCallum Cancer Centre, Australia

Recruiting

Genetically Risk-Stratified Venetoclax, Ibrutinib, Rituximab (± Navitoclax) in Relapsed/Refractory Mantle Cell Lymphoma

Mantle Cell Lymphoma Refractory

Australia
Professor Michael Bourke

Completed

Non-invasive Risk Stratification of CR AMN/SSP (FIT)

Adenomatous Polyps

Australia
ETOP IBCSG Partners Foundation

Completed

Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases (23-01)

Breast Cancer

France, Switzerland, Australia, Peru, Italy, New Zealand, Slovenia, Belgium, Brazil, Denmark
Eli Lilly and Company

Terminated

Enzastaurin in Combination of Capecitabine to Treat Breast Cancer

Breast Cancer

Mexico, France, Australia, Argentina, South Africa
Checkpoint Therapeutics, Inc.
Novotech (Australia) Pty Limited

Recruiting

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

Melanoma | Renal Cell Carcinoma | Head and Neck Cancer | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Non Hodgkin Lymphoma | Endometrial Cancer | Carcinoma, Small Cell | Urothelial Carcinoma | Classical Hodgkin Lymphoma | Merkel Cell Carcinoma | Cutaneous Squamous Cell Carcinoma | Malignant Mesothelioma, Advanced

Australia, New Zealand, Thailand, Ukraine, Spain, Russian Federation, France, Poland, South Africa
The University of Western Australia

Completed

Randomised Crossover Trial of DBS of Differential PSA Regions in Parkinson's Disease and Tremor

Parkinson's Disease | Tremor

Australia
Bayside Health

Unknown

Atorvastatin in Myeloma

Myeloma

Australia
Bristol-Myers Squibb

Completed

Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors

Neoplasms | Solid Tumors | Metastases

Australia
Royal North Shore Hospital

Completed

Early Investigation of High Precision Radiotherapy Prior to Commencing Standard Radiotherapy for Prostate Cancer (BOOSTER)

Prostate Cancer

Australia
Melanoma Institute Australia
Bristol-Myers Squibb

Recruiting

A Phase 2 Clinical Trial of Neoadjuvant Relatlimab and Nivolumab in High Risk, Clinical Stage II Cutaneous Melanoma (Neo ReNi II)

Stage II Melanoma

Australia
Royal North Shore Hospital

Active, not recruiting

Liver Function Investigation With SPECT (LiverINSPECT)

Liver Cancer, Adult

Australia
Genzyme, a Sanofi Company

Completed

Phase I FOLFOX Combination

Advanced Colorectal Carcinoma

Australia
Prescient Therapeutics, Ltd.

Recruiting

Phase 1 Study of PTX-100 in Patients With Advanced Malignancies With PTCL Expansion Cohort

Advanced Cancer | PTCL

Australia
Cellxpert Biotechnology Corp.
Medigen Biotechnology Corporation

Completed

Docetaxel With or Without PI-88 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

Australia
Peplin

Completed

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma

Basal Cell Carcinoma

Australia
Fermiscan Ltd

Unknown

Use of Hair to Diagnose Breast Cancer

Breast Cancer

Australia
Western Sydney Local Health District

Recruiting

The Australian Colonic Large Sessile Lesion Endoscopic Resection Study (ACE)

Colon Adenoma | Colon Polyp

Australia
Ambrx, Inc.

Completed

A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)

Breast Neoplasms | Solid Tumors | Gastric Neoplasm

United States, Australia
Royal North Shore Hospital
University of Sydney; Varian Medical Systems

Active, not recruiting

Lung Cancer Radiotherapy Using Realtime Dynamic Multileaf Collimator (MLC) Adaptation And Radiofrequency Tracking (LIGHTSABR)

Neoplasms | Lung Neoplasms

Australia
Royal North Shore Hospital

Withdrawn

Multi-target Tracking in Prostate Radiotherapy Using MLC and KIM (KOALA)

Prostate Cancer

Australia
Peter MacCallum Cancer Centre, Australia
Melbourne Health

Completed

NMP in Relapsed / Refractory Myeloma

Multiple Myeloma

Australia
Peter MacCallum Cancer Centre, Australia

Recruiting

NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma (NAPSTER)

Renal Cell Carcinoma, Clear Cell, Somatic

Australia
Western Sydney Local Health District

Completed

Prediction of Dysplasia Within Sessile Serrated Polyps Using Endoscopic Imaging; a Prospective Observational Study (SERRESH)

Sessile Serrated Adenoma

Australia
Fermiscan Ltd

Unknown

Use of Hair to Diagnose the Presence of Breast Cancer

Breast Cancer

Australia
Bayside Health

Completed

Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma

Non-Hodgkin's Lymphoma (CD20+)

Australia
Surgical Outcomes Research Centre (SOuRCe)

Recruiting

PRIORITY-CONNECT 2 Pilot Trial

Gastric Cancer | Colorectal Cancer | Pancreas Cancer | Liver Cancer | Oesophageal Cancer

Australia
Arbele Pty Ltd

Recruiting

Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients

Gastric Cancer | Pancreatic Cancer | Cholangiocarcinoma | Esophageal Adenocarcinoma | Gastrointestinal Cancer | Liver Cancer | Colorectal Adenocarcinoma | Gastroesophageal Junction

Hong Kong, Australia
St Vincent's Hospital, Sydney

Recruiting

Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer (4CAST)

Triple Negative Breast Cancer

Australia
St George Hospital, Australia

Recruiting

Hemiablative Focal Brachytherapy Pilot Study

Prostate Cancer

Australia
Royal North Shore Hospital
University of Sydney

Completed

Feasibility Study Into Adjustment of the Radiation Beam to Account for Prostate Motion During Radiotherapy. (CALYPSO)

Prostate Cancer

Australia

Clinical Trials on Malignant Meningeal Neoplasms in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations